Norris Medicines Ltd.
BSE: 524414 | Sector: Others |
NSE: N.A. | ISIN Code: INE744C01029 |
BSE 00:00 | 26 Feb | 6.00 |
0 (0.00%) |
OPEN
6.00 |
HIGH
6.00 |
LOW
6.00 |
NSE 05:30 | 01 Jan | Norris Medicines Ltd |
OPEN | 6.00 |
PREVIOUS CLOSE | 6.00 |
VOLUME | 40 |
52-Week high | 6.30 |
52-Week low | 2.45 |
P/E | |
Mkt Cap.(Rs cr) | 6 |
Buy Price | 6.00 |
Buy Qty | 984.00 |
Sell Price | 6.00 |
Sell Qty | 16.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Norris Medicines Ltd. (NORRISMEDICINES) - Financial Overview
Particulars (![]() |
2020 | 2019 | 2018 |
Net Sales | 7.84 | 16.26 | 13.57 |
Operating Profit | -2.07 | -0.57 | -1.77 |
Other Income | 0.09 | 0.04 | 0.14 |
Interest | 0.88 | 0.73 | 0.70 |
Depreciation | 0.73 | 0.71 | 0.71 |
Profit Before Tax | -3.68 | -2.01 | -3.18 |
Tax | -0.84 | -0.33 | -0.67 |
Profit After Tax | -2.84 | -1.68 | -2.51 |
Share Capital | 9.93 | 9.93 | 9.93 |
Reserves | -12.39 | -9.55 | -7.88 |
Net Worth | -2.46 | 0.38 | 2.05 |
Loans | 14.98 | 11.24 | 7.71 |
Gross Block | 27.78 | 27.70 | 27.41 |
Investments | 0.01 | 0.01 | 0.01 |
Cash | 0.06 | 0.08 | 0.10 |
Debtors | 2.76 | 3.01 | 2.47 |
Net Working Capital | 4.26 | 2.70 | 0.43 |
Operating Profit Margin (%) | -26.40 | -3.51 | -13.04 |
Net Profit Margin (%) | -36.22 | -10.33 | -18.50 |
Earning Per Share (Rs) | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 |
Dividend Payout | 0.00 | 0.00 | 0.00 |
Quick Links for Norris Medicines:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices